Nucleus RadioPharma

With Society of Nuclear Medicine and Molecular Imaging (SNMMI)'s Therapeutics Conference being just six days away, the Nucleus RadioPharma team wants to highlight a session that two of our Scientific Advisory Board members, Andrei Iagaru and Oliver Sartor, will be organizing and speaking at. The Clinical Trails & Research in Therapeutics session will start at 1:05 on September 19th, 2024. You won’t want to miss it!?? Interested in connecting during the conference? ?? Email [email protected]. #SNMMI #Therapeutics #Radiopharmaceuticals #ClinicalTrials

Nucleus RadioPharma is thrilled to be a sponsor of the 3rd Edition #TackleCancerChallenge with the Oncidium foundation! Our team cannot wait to raise awareness for #radiotheranostics and aide in the support for cancer patients. Go Team Nucleus! Stay tuned for exciting updates. ??♂?

Nucleus RadioPharma's Chief Executive Officer, Charles Conroy, RPh, MBA, and Scientific Advisory Board Co-Chair, Oliver Sartor, recently discussed our role in radiopharmaceutical #manufacturing and #distribution. Chuck touched on Nucleus' plans for expansion saying, "We're currently finishing out our Rochester facility. . . In addition to that, we're building out two very large facilities that we'll be announcing very soon, one on the East Coast and one on the West Coast that will significantly alter the state of manufacturing capabilities across North America. So we'll actually be putting into the ground more manufacturing capacity than exists across the world today." Listen to the full interview here: https://hubs.ly/Q02Pxcvc0 #Radiopharmaceuticals #CDMO #CancerCare

Almost one week until the Nucleus RadioPharma team hits the road headed to Bethesda, MD for Society of Nuclear Medicine and Molecular Imaging (SNMMI)'s Therapeutics Conference and two weeks until Targeted Radiopharmaceuticals Manufacturing and Supply Chain Summit in Boston, MA! Attendees: What topic are you hoping to learn more about while you are there? Reach out to [email protected] to discuss and set up a time to meet. #SNMMI #TRP #Radiopharmaceuticals #CDMO

During #ProstateCancerAwarenessMonth, it is important to stay informed about the facts and statistics. Prostate cancer is the most common cancer in men in the US, other than skin cancer. It's also the second-leading cause of cancer death (after lung cancer). About 1 in 8 men will get prostate cancer in their lifetime. Luckily, there are 500+ Phase I/II clinical trials and almost 100 Phase III clinical trials related to prostate cancer in the United States. Nucleus RadioPharma is hopeful that together with these trials, patient outcomes will be greatly improved. This September, we are polling on an important Public Service Announcement (PSA). #PCAM2024 #ProstateCancer #CancerCare #RLT

?? Nucleus RadioPharma is Proud to Support #ProstateCancerAwarenessMonth! ?? This September, we’re highlighting prostate cancer. Cutting-edge radiotherapy innovations in #Biotech and #Pharma are revolutionizing prostate cancer treatment, offering new hope and precision care for those affected. At Nucleus, we're committed to advancing the fight against cancer by expanding our end-to-end contract manufacturing capabilities. Our mission? To build robust, reliable supply chains for targeted radiotherapies, empowering radiopharmaceutical companies and innovators to deliver life-saving treatments to patients. This Prostate Cancer Awareness Month, we celebrate the breakthroughs that are changing lives. Let’s come together to raise awareness and drive progress in the fight against prostate cancer! #PCAM2024 #Radiopharmaceuticals #CancerCare #GetChecked

Searching for your next role in #radiopharma? Better culture and careers await! ? Learn more about what it's like to work for Nucleus RadioPharma: https://hubs.ly/Q02Mwr9Z0 #Radiopharmaceuticals #JoinUs #Hiring

It's not just what we do, it's HOW we do it. Looking for an end-to-end #radiopharmaceutical #CDMO partner? Let's talk. Email [email protected] or visit our website at https://hubs.ly/Q02MWtcm0. #Theranostics #RLT #CancerCare

EMPLOYEE SPOTLIGHT: Meet our VP of Supply Chain, Jim Dolan! ?? A few facts about Jim: ?? He started his career on the diagnostic side of the industry and saw first-hand how those agents changed patient care (in some cases, dramatically). ?? Now, with Nucleus RadioPharma he’s excited to develop and bring new therapies to market that have the same potential to positively impact patient outcomes. He says, “At the end of the day, that's really what we're all here to do.” ?? He says Nucleus’ team of seasoned experts from every corner of the radiopharmaceutical industry and our broad, isotope-agnostic approach make us different than other #CDMOs. #EmployeeSpotlight #OurNucleus #Radiopharmaceuticals #SupplyChain

Proud to be one of XCancer Research's trusted #RLT manufacturing collaborators. ?? Learn more about Nucleus, XCancer, and our Scientific Advisory Board member, Luke Nordquist MD FACP: https://hubs.ly/Q02M5RNq0 #Theranostics #Radiopharmaceuticals #Collaboration